- Home
- CRGX vs AMBC Comparison
CRGX vs AMBC Comparison
Compare CRGX & AMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRGX
- AMBC
- Stock Information
- Founded
- CRGX 2021
- AMBC 1991
- Country
- CRGX United States
- AMBC United States
- Employees
- CRGX N/A
- AMBC N/A
- Industry
- CRGX
- AMBC Property-Casualty Insurers
- Sector
- CRGX
- AMBC Finance
- Exchange
- CRGX Nasdaq
- AMBC Nasdaq
- Market Cap
- CRGX 628.6M
- AMBC 543.0M
- IPO Year
- CRGX 2023
- AMBC 1991
- Fundamental
- Price
- CRGX $3.70
- AMBC $11.51
- Analyst Decision
- CRGX Hold
- AMBC Strong Buy
- Analyst Count
- CRGX 7
- AMBC 2
- Target Price
- CRGX $4.67
- AMBC $17.00
- AVG Volume (30 Days)
- CRGX 1.9M
- AMBC 431.2K
- Earning Date
- CRGX 03-20-2025
- AMBC 02-25-2025
- Dividend Yield
- CRGX N/A
- AMBC N/A
- EPS Growth
- CRGX N/A
- AMBC N/A
- EPS
- CRGX N/A
- AMBC N/A
- Revenue
- CRGX N/A
- AMBC $398,000,000.00
- Revenue This Year
- CRGX N/A
- AMBC N/A
- Revenue Next Year
- CRGX N/A
- AMBC N/A
- P/E Ratio
- CRGX N/A
- AMBC N/A
- Revenue Growth
- CRGX N/A
- AMBC 22.46
- 52 Week Low
- CRGX $3.00
- AMBC $10.12
- 52 Week High
- CRGX $33.92
- AMBC $18.45
- Technical
- Relative Strength Index (RSI)
- CRGX 20.88
- AMBC 45.24
- Support Level
- CRGX $3.00
- AMBC $11.35
- Resistance Level
- CRGX $3.88
- AMBC $11.72
- Average True Range (ATR)
- CRGX 0.92
- AMBC 0.31
- MACD
- CRGX -1.00
- AMBC 0.05
- Stochastic Oscillator
- CRGX 5.99
- AMBC 59.15
About CRGX CARGO Therapeutics Inc.
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.
About AMBC Ambac Financial Group Inc.
Ambac Financial Group Inc is a financial services holding company. The business operations of the company include Legacy Financial Guarantee Insurance, Specialty Property and Casualty Insurance and Insurance Distribution. The Company has three reportable segments namely Legacy Financial Guarantee Insurance, Specialty Property and Casualty Insurance and Insurance Distribution. Majority of revenues are earned from Legacy Financial Guarantee Insurance segment.